Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) — Equity-Insider.com News Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faste
(Financial Post, 2025-12-16T17:22:25Z)